ADA 2025 Recap: Cures
Breakthrough T1D was in Chicago, IL for ADA 2025. Here we report on the latest advancements in cures for type…
ADA 2025 Recap: Improving Lives
Improving Lives Breakthrough T1D’s Improving Lives program focuses on devices, insulins, adjunctive therapies, treatments for complications, and psychosocial interventions to…
Golf champion’s story highlights importance of screening for type 1 diabetes in adults
J.J. Spaun’s diagnosis story highlights the importance of screening and monitoring for type 1 diabetes in people of all ages.
The (r)evolution of a rider
Breakthrough T1D Ride has given Matt Edgington the confidence and support he needs to live a full and healthy life…
Breakthrough T1D heads to ADA’s 85th Scientific Sessions
Breakthrough T1D is heading to Chicago, IL to attend the 2025 ADA conference from June 20-23 to discuss cutting-edge type…
Accelerating cures: Four new grants from the Breakthrough T1D x Stem Cell Network Partnership
Breakthrough T1D, Breakthrough T1D Canada, and the Stem Cell Network (SCN) have partnered to support cell therapy research in Canada.
Making cures a reality: Clinical adoption of cell therapies
The Medical Affairs team is working to ensure the clinical adoption of forthcoming manufactured cell therapies.
Ketones, diabetic ketoacidosis, and type 1 diabetes
Learn more about ketones, what ketone levels mean, and the symptoms of diabetic ketoacidosis (DKA).
Breakthrough T1D and Partners Thank NIH Director For Commitment to Continuing Research in FY25
Breakthrough T1D and other research and patient advocacy organizations recently had the opportunity to meet with National Institute of Health…
Breakthrough T1D helps organize an event at the European Parliament about unmet needs for T1D and accelerating cures
This meeting focused on the role of the EU in addressing the needs of the T1D community and accelerating T1D…
